Tumor Microenvironment Triggered In Situ Coagulation of Supramolecularly Engineered Platelets for Precise Tumor Embolization

Abstract Although embolization therapy has demonstrated success in impeding tumor growth, concerns persist regarding potential tumor recurrence and inadvertent embolization of non‐target tissues. In this study, drawing inspiration from the natural targeting and coagulation process of platelets in in...

Full description

Saved in:
Bibliographic Details
Main Authors: Junyan Li, Ziyi Wang, Ruifeng Luo, Xingping Quan, Hong U Fong, Qian Cheng, Jianwen Wei, Leo Wang, Yonghua Zhao, Ruibing Wang
Format: Article
Language:English
Published: Wiley 2025-07-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202414879
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849765180972466176
author Junyan Li
Ziyi Wang
Ruifeng Luo
Xingping Quan
Hong U Fong
Qian Cheng
Jianwen Wei
Leo Wang
Yonghua Zhao
Ruibing Wang
author_facet Junyan Li
Ziyi Wang
Ruifeng Luo
Xingping Quan
Hong U Fong
Qian Cheng
Jianwen Wei
Leo Wang
Yonghua Zhao
Ruibing Wang
author_sort Junyan Li
collection DOAJ
description Abstract Although embolization therapy has demonstrated success in impeding tumor growth, concerns persist regarding potential tumor recurrence and inadvertent embolization of non‐target tissues. In this study, drawing inspiration from the natural targeting and coagulation process of platelets in injured blood vessels, platelets are engineered by integrating acid‐sensitive, morphology‐transformable nanoparticles onto their surface through supramolecular conjugation (PLT‐NP). The nanoparticles are constructed through the self‐assembly of a β‐amyloid derived peptide (FFVLK) terminally functionalized with Fmoc, hexahistidine (His6), and a polyethylene glycol (PEG)‐functionalized cyclodextrin (CD). The supramolecularly engineered platelets actively accumulate in the tumor tissue upon inducing a tumor blood vessel injury through tumor resection. In response to the local acidic microenvironment, the nanoparticles undergo a morphological transformation into nanofibers via spontaneous assembly of FFLVK into fibril structures through hydrogen bonding and β‐sheet interactions, to artificially enhance the coagulation and aggregation of platelets, causing occlusion of tumor blood vessels. The supramolecularly engineered platelets efficiently embolize tumor blood vessels in a specific manner, effectively suppressing tumor growth, metastasis, and recurrence, thus offering a promising paradigm for combating cancer.
format Article
id doaj-art-2dce9640e9dd4925aac29304f5a764ff
institution DOAJ
issn 2198-3844
language English
publishDate 2025-07-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-2dce9640e9dd4925aac29304f5a764ff2025-08-20T03:04:57ZengWileyAdvanced Science2198-38442025-07-011226n/an/a10.1002/advs.202414879Tumor Microenvironment Triggered In Situ Coagulation of Supramolecularly Engineered Platelets for Precise Tumor EmbolizationJunyan Li0Ziyi Wang1Ruifeng Luo2Xingping Quan3Hong U Fong4Qian Cheng5Jianwen Wei6Leo Wang7Yonghua Zhao8Ruibing Wang9State Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao SAR 999078 ChinaState Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao SAR 999078 ChinaState Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao SAR 999078 ChinaState Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao SAR 999078 ChinaState Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao SAR 999078 ChinaState Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao SAR 999078 ChinaState Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao SAR 999078 ChinaState Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao SAR 999078 ChinaState Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao SAR 999078 ChinaState Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao SAR 999078 ChinaAbstract Although embolization therapy has demonstrated success in impeding tumor growth, concerns persist regarding potential tumor recurrence and inadvertent embolization of non‐target tissues. In this study, drawing inspiration from the natural targeting and coagulation process of platelets in injured blood vessels, platelets are engineered by integrating acid‐sensitive, morphology‐transformable nanoparticles onto their surface through supramolecular conjugation (PLT‐NP). The nanoparticles are constructed through the self‐assembly of a β‐amyloid derived peptide (FFVLK) terminally functionalized with Fmoc, hexahistidine (His6), and a polyethylene glycol (PEG)‐functionalized cyclodextrin (CD). The supramolecularly engineered platelets actively accumulate in the tumor tissue upon inducing a tumor blood vessel injury through tumor resection. In response to the local acidic microenvironment, the nanoparticles undergo a morphological transformation into nanofibers via spontaneous assembly of FFLVK into fibril structures through hydrogen bonding and β‐sheet interactions, to artificially enhance the coagulation and aggregation of platelets, causing occlusion of tumor blood vessels. The supramolecularly engineered platelets efficiently embolize tumor blood vessels in a specific manner, effectively suppressing tumor growth, metastasis, and recurrence, thus offering a promising paradigm for combating cancer.https://doi.org/10.1002/advs.202414879cell carriersembolization therapymorphology transformationplateletssupramolecular
spellingShingle Junyan Li
Ziyi Wang
Ruifeng Luo
Xingping Quan
Hong U Fong
Qian Cheng
Jianwen Wei
Leo Wang
Yonghua Zhao
Ruibing Wang
Tumor Microenvironment Triggered In Situ Coagulation of Supramolecularly Engineered Platelets for Precise Tumor Embolization
Advanced Science
cell carriers
embolization therapy
morphology transformation
platelets
supramolecular
title Tumor Microenvironment Triggered In Situ Coagulation of Supramolecularly Engineered Platelets for Precise Tumor Embolization
title_full Tumor Microenvironment Triggered In Situ Coagulation of Supramolecularly Engineered Platelets for Precise Tumor Embolization
title_fullStr Tumor Microenvironment Triggered In Situ Coagulation of Supramolecularly Engineered Platelets for Precise Tumor Embolization
title_full_unstemmed Tumor Microenvironment Triggered In Situ Coagulation of Supramolecularly Engineered Platelets for Precise Tumor Embolization
title_short Tumor Microenvironment Triggered In Situ Coagulation of Supramolecularly Engineered Platelets for Precise Tumor Embolization
title_sort tumor microenvironment triggered in situ coagulation of supramolecularly engineered platelets for precise tumor embolization
topic cell carriers
embolization therapy
morphology transformation
platelets
supramolecular
url https://doi.org/10.1002/advs.202414879
work_keys_str_mv AT junyanli tumormicroenvironmenttriggeredinsitucoagulationofsupramolecularlyengineeredplateletsforprecisetumorembolization
AT ziyiwang tumormicroenvironmenttriggeredinsitucoagulationofsupramolecularlyengineeredplateletsforprecisetumorembolization
AT ruifengluo tumormicroenvironmenttriggeredinsitucoagulationofsupramolecularlyengineeredplateletsforprecisetumorembolization
AT xingpingquan tumormicroenvironmenttriggeredinsitucoagulationofsupramolecularlyengineeredplateletsforprecisetumorembolization
AT hongufong tumormicroenvironmenttriggeredinsitucoagulationofsupramolecularlyengineeredplateletsforprecisetumorembolization
AT qiancheng tumormicroenvironmenttriggeredinsitucoagulationofsupramolecularlyengineeredplateletsforprecisetumorembolization
AT jianwenwei tumormicroenvironmenttriggeredinsitucoagulationofsupramolecularlyengineeredplateletsforprecisetumorembolization
AT leowang tumormicroenvironmenttriggeredinsitucoagulationofsupramolecularlyengineeredplateletsforprecisetumorembolization
AT yonghuazhao tumormicroenvironmenttriggeredinsitucoagulationofsupramolecularlyengineeredplateletsforprecisetumorembolization
AT ruibingwang tumormicroenvironmenttriggeredinsitucoagulationofsupramolecularlyengineeredplateletsforprecisetumorembolization